https://www.pharmanow.live/latest-news/viatris-acquires-pacira-biosciences-regulatory-approvals-innovative-medicines-pivot 2026-11-06T13:01:20+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Viatris Advances Pacira Acquisition as Innovative Medicines Pivot Viatris https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/viatris-pacira-acquisition-regulatory-approvals-innovative-medicines-strategy-202620261106130109.webp https://www.pharmanow.live/latest-news/telix-pharmaceuticals-joins-thera4care-consortium-tlx400-tx-fap-targeting-theranostics-europe 2026-11-06T12:53:10+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Telix Joins Thera4Care Consortium to Advance FAP-Targeted Therapy Telix https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/telix-thera4care-consortium-tlx400-tx-terbium-161-fap-theranostics-202620261106125146.webp https://www.pharmanow.live/latest-news/bayer-gains-china-first-line-approval-sevabertinib-her2-mutated-advanced-lung-cancer 2026-11-06T12:46:03+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Bayer Wins China First-Line Approval for Sevabertinib in NSCLC Bayer https://www.pharmanow.live/latest-news/evotec-secures-vertex-commercial-manufacturing-deal-povetacicept-jpod-redmond 2026-11-06T12:25:40+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Evotec Wins Vertex Commercial Manufacturing Role for Povetacicept Evotec https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/evotec-vertex-povetacicept-commercial-manufacturing-jpod-redmond-202620261106122406.webp https://www.pharmanow.live/latest-news/alembic-pharma-difgen-partnership-us-complex-generics 2026-11-06T12:14:59+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Alembic Expands DifGen Partnership for US Complex Generics Alembic https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/alembic-difgen-partnership-us-complex-generics-20-products-202620261106121415.webp https://www.pharmanow.live/latest-news/fresenius-wuxi-biologics-deal-biosimilar-pipeline-66-molecules 2026-11-06T12:00:57+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Fresenius Teams With WuXi on 66-Molecule Biosimilar Pipeline Fresenius https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/fresenius-wuxi-biologics-biosimilar-pipeline-66-molecules-202620261106120048.webp https://www.pharmanow.live/latest-news/oryzon-iadademstat-phase-ib-aml-ash-2026-phase-iii-pivot 2026-11-06T11:48:44+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Oryzon Reports 95% ORR in Phase Ib AML Trial Ahead of Phase III Oryzon https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/oryzon-iadademstat-95-percent-orr-phase-ib-aml-trial-ash-202620261106114821.webp https://www.pharmanow.live/latest-news/merck-launches-phase-3-trial-ohtuvayre-copd-exacerbations 2026-11-06T11:43:43+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Merck Launches Phase 3 OHTUVAYRE Trial for COPD Exacerbations Merck https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/merck-ohtuvayre-enhance-3-phase-3-copd-exacerbation-trial-202620261106114120.webp https://www.pharmanow.live/latest-news/medicus-pharma-spac-loi-skinject-135-million-business-combination 2026-11-06T11:34:32+05:30 Pharma Now en 2026-11-05T00:00:00+05:30 Medicus Proposes $135M SkinJect Business Combination With SPAC Medicus https://pharmanow.nyc3.cdn.digitaloceanspaces.com/p/uploads/news/original/medicus-pharma-skinject-135-million-spac-business-combination-202620261106112654.webp